CTOs on the Move

Evergreen Research

www.evergreenresearch.com

 
Evergreen Research Corporation has performed contract product development with an emphasis on medical devices since 1988. Evergreen Research offers a complete range of development services from product definition and feasibility studies through detailed design to pilot-run and low-volume production.Their experience and resourceful staff, seasoned program management, and knowledge of regulations ensure customer satisfaction and compliance with regulatory requirements. Evergreen Research, Inc. also known as ERI, has developed advanced electromechanical and software-based products providing a complete range of development services, such as product requirements definition, project planning, risk management, comprehensive design expertise (electrical, mechanical, software and industrial), design documentation, verification and validation, ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
John Nichols
 Director Of Product Development Profile

Similar Companies

Transfer Master Products Inc

Transfer Master Products Inc is a Postville, IA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

medikmark

medikmark, Inc. is a Waukegan, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

North American Medical Management

For over a decade, NAMM California has championed physician driven medical groups resulting in superior quality health care for patients. North American Medical Management, California (NAMM California) develops and manages medical groups providing a

Dataray

Dataray is a Oklahoma City, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ResMed

ResMed (NYSE: RMD, ASX: RMD), a world-leading connected health company with more than 4 million cloud-connected devices for daily remote patient monitoring, changes lives with every breath. Its award-winning devices and software solutions help treat and manage sleep apnea, chronic obstructive pulmonary disease and other respiratory conditions. Its 6,000-member team strives to improve patients’ quality of life, reduce the impact of chronic disease and save healthcare costs in more than 120 countries.